[Biosimilar drugs – just as good, and much cheaper]

Tidsskr Nor Laegeforen. 2019 Mar 19;139(6). doi: 10.4045/tidsskr.19.0051. Print 2019 Mar 26.
[Article in Norwegian]
No abstract available

Publication types

  • Editorial

MeSH terms

  • Biosimilar Pharmaceuticals* / economics
  • Biosimilar Pharmaceuticals* / pharmacokinetics
  • Biosimilar Pharmaceuticals* / standards
  • Cost Savings
  • Drug Costs
  • Humans
  • Therapeutic Equivalency

Substances

  • Biosimilar Pharmaceuticals